by Clinical Neuropsychologist Online | Monday, September 23, 2024 | Dementia
Abstract INTRODUCTION The microglial receptor triggering receptor expressed on myeloid cells 2 (TREM2) is a major risk factor for Alzheimer’s disease (AD). Experimentally, Trem2 deficiency affects parenchymal amyloid beta (Aβ) deposition. However, the role of...
by Clinical Neuropsychologist Online | Sunday, September 22, 2024 | Dementia
Abstract The emergence of the United States Food and Drug Administration (FDA)-approved amyloid-targeting therapies for Alzheimer’s disease challenges clinicians and healthcare providers with a transformative landscape. Effectively communicating the risks,...
by Clinical Neuropsychologist Online | Saturday, September 21, 2024 | Dementia
Dementia, Volume 24, Issue 3, Page 552-576, April 2025. Aim:to explore the range of cultural understandings of dementia held by people providing nursing care globally.Background:There is a worldwide shortage of nurses and healthcare workers, resulting in extensive...
by Clinical Neuropsychologist Online | Thursday, September 19, 2024 | Dementia
Dementia, Volume 24, Issue 2, Page 214-234, February 2025. The number of caregivers and people living with dementia and other related forms of cognitive impairment is increasing worldwide. Compared to heterosexual and cisgender individuals, studies suggest that...
by Clinical Neuropsychologist Online | Wednesday, September 18, 2024 | Dementia
Dementia, Volume 24, Issue 1, Page 14-22, January 2025. The lived experience of dementia, the views of the caregiver, and the pursuit of scientific understanding by researchers need to converge for holistic and collaborative action to improve dementia research....
